| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 211,248 | 201,614 | 214,023 | 244,711 | | Cost of Revenue | 139,252 | 136,692 | 144,721 | 170,819 | | | Gross Profit | 71,996 | 64,922 | 69,302 | 73,892 | | | Operating Expenses | | Research Development | 15,554 | 15,024 | 17,872 | 18,443 | | Selling General and Administrative | 25,585 | 35,452 | 50,135 | 53,954 | | Non Recurring |
-
| (2,745) | 178,257 | 289,119 | | Others | 4,835 | 4,827 | 5,871 | 7,178 | | | | Total Operating Expenses |
-
| 52,558 | 252,135 | 368,694 | | | | Operating Income or Loss | 26,022 | 12,364 | (182,833) | (294,802) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,427) | 14,150 | 4,861 | (5,637) | | Earnings Before Interest And Taxes | 21,595 | 26,514 | (177,972) | (300,439) | | Interest Expense | (988) | 4,285 | 5,361 | 6,536 | | Income Before Tax | 22,583 | 22,229 | (183,333) | (306,975) | | Income Tax Expense | 673 | 3,673 | (1,344) | 59,663 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 21,910 | 18,556 | (181,989) | (366,638) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 21,910 | 18,556 | (181,989) | (366,638) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $21,910 | $18,556 | ($181,989) | ($366,638) |
|
0.28% Nasdaq 
Income Statement
